UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Effects of Vestibular Rehabilitation on Multiple Sclerosis–Related Fatigue and Upright Postural Control: A Randomized Controlled Trial

Physical therapy, 2011-08, Vol.91 (8), p.1166-1183

2011

Link zum Volltext

Verfügbarkeit prüfen

Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Therapeutic advances in neurological disorders, 2021, Vol.14, p.175628642110195-17562864211019567

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations

Neuro-oncology (Charlottesville, Va.), 2016-03, Vol.18 Suppl 2 (suppl 2), p.ii13-ii20

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis-Variations in Real-World Experience

JAMA neurology, 2024-01, Vol.81 (1), p.87

2024

Link zum Volltext

Verfügbarkeit prüfen

Multiple sclerosis prevalence in the United States commercially insured population

Neurology, 2016-03, Vol.86 (11), p.1014

2016

Link zum Volltext

Verfügbarkeit prüfen

Adjustments in Torque Steadiness During Fatiguing Contractions Are Inversely Correlated With IQ in Persons With Multiple Sclerosis

Frontiers in physiology, 2018-10, Vol.9, p.1404-1404

2018

Link zum Volltext

Verfügbarkeit prüfen

Reducing costs while enhancing quality of care in MS

Neurology, 2016-10, Vol.87 (15), p.1617

2016

Link zum Volltext

Verfügbarkeit prüfen

TMEM106B Puncta Is Increased in Multiple Sclerosis Plaques, and Reduced Protein in Mice Results in Delayed Lipid Clearance Following CNS Injury

Cells (Basel, Switzerland), 2023-06, Vol.12 (13), p.1734

2023

Link zum Volltext

Verfügbarkeit prüfen

Another sphingosine 1-phosphate receptor modulator for the treatment of patients with multiple sclerosis

Lancet neurology, 2019-11, Vol.18 (11), p.983-985

2019

Link zum Volltext

Verfügbarkeit prüfen

Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go?

JAMA neurology, 2021-07, Vol.78 (7), p.787

2021

Link zum Volltext

Verfügbarkeit prüfen

Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis

Neurology, 2019-02, Vol.92 (7), p.e723

2019

Link zum Volltext

Verfügbarkeit prüfen

Differential diagnosis of suspected multiple sclerosis: an updated consensus approach

Lancet neurology, 2023-08, Vol.22 (8), p.750-768

2023

Link zum Volltext

Verfügbarkeit prüfen

Challenging Cases in Neuroimmunology

Seminars in neurology, 2022-12, Vol.42 (6), p.695

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-world practice

Neurology. Clinical practice, 2018-08, Vol.8 (4), p.275-275

Corboy, John R

2018

Link zum Volltext

Verfügbarkeit prüfen

Tools to address health care delivery challenges and improve patient outcomes

Neurology. Clinical practice, 2018-12, Vol.8 (6), p.463-463

Corboy, John R

2018

Link zum Volltext

Verfügbarkeit prüfen

Strength in numbers

Neurology. Clinical practice, 2018-10, Vol.8 (5), p.363-363

Corboy, John R

2018

Link zum Volltext

Verfügbarkeit prüfen

Providing patient-centered care in the digital era

Neurology. Clinical practice, 2018-06, Vol.8 (3), p.171-171

Corboy, John R

2018

Link zum Volltext

Verfügbarkeit prüfen

Partners in enhancing functional ability and well-being

Neurology. Clinical practice, 2018-04, Vol.8 (2), p.83-83

Corboy, John R

2018

Link zum Volltext

Verfügbarkeit prüfen

The physician as captain of the patient-centered ship

Neurology. Clinical practice, 2018-02, Vol.8 (1), p.1-1

Corboy, John R

2018

Link zum Volltext

Verfügbarkeit prüfen

The effects of test-enhanced learning on long-term retention in AAN annual meeting courses

Neurology, 2015-02, Vol.84 (7), p.748

2015

Link zum Volltext

Verfügbarkeit prüfen

Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A randomized, placebo-controlled, multiple-dose study

Multiple sclerosis and related disorders, 2014-11, Vol.3 (6), p.696-704

2014

Link zum Volltext

Verfügbarkeit prüfen

Single-Cell Repertoire Analysis Demonstrates that Clonal Expansion Is a Prominent Feature of the B Cell Response in Multiple Sclerosis Cerebrospinal Fluid

The Journal of immunology (1950), 2003-09, Vol.171 (5), p.2725-2733

2003

Link zum Volltext

Verfügbarkeit prüfen

Rituximab-induced serum sickness in multiple sclerosis patients

Multiple sclerosis and related disorders, 2019-11, Vol.36, p.101402-101402, Article 101402

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(70)
Clinical Neurology
(50)
Neurosciences & Neurology
(50)
Humans
(42)
Female
(20)
Multiple Sclerosis
(19)
From The Editor's Desk
(18)
Male
(17)
Adult
(16)
Middle Aged
(16)
Neurology
(14)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Magnetic Resonance Imaging
(10)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(7)
United States
(7)
Adolescent
(6)
Aged
(5)
Child
(5)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of Vestibular Rehabilitation on Multiple Sclerosis–Related Fatigue and Upright Postural Control: A Randomized Controlled Trial

Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations

Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis-Variations in Real-World Experience

Multiple sclerosis prevalence in the United States commercially insured population

Adjustments in Torque Steadiness During Fatiguing Contractions Are Inversely Correlated With IQ in Persons With Multiple Sclerosis

Reducing costs while enhancing quality of care in MS

TMEM106B Puncta Is Increased in Multiple Sclerosis Plaques, and Reduced Protein in Mice Results in Delayed Lipid Clearance Following CNS Injury

Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial

Another sphingosine 1-phosphate receptor modulator for the treatment of patients with multiple sclerosis

Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go?

Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis

Differential diagnosis of suspected multiple sclerosis: an updated consensus approach

Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial

Challenging Cases in Neuroimmunology

Real-world practice

Tools to address health care delivery challenges and improve patient outcomes

Strength in numbers

Providing patient-centered care in the digital era

Partners in enhancing functional ability and well-being

The physician as captain of the patient-centered ship

The effects of test-enhanced learning on long-term retention in AAN annual meeting courses

Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A randomized, placebo-controlled, multiple-dose study

Single-Cell Repertoire Analysis Demonstrates that Clonal Expansion Is a Prominent Feature of the B Cell Response in Multiple Sclerosis Cerebrospinal Fluid

Rituximab-induced serum sickness in multiple sclerosis patients

Aktive Filter

Suchergebnisse filtern